Indication
MRCP
1 clinical trial
1 product
Clinical trial
A Clinical Study on the Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP PancreatitisStatus: Completed, Estimated PCD: 2023-12-06
Product
Indomethacin1 clinical trial
1 product